Duwe Lea, Munoz-Garrido Patricia, Lewinska Monika, Lafuente-Barquero Juan, Satriano Letizia, Høgdall Dan, Taranta Andrzej, Nielsen Boye S, Ghazal Awaisa, Matter Matthias S, Banales Jesus M, Aldana Blanca I, Gao Yu-Tang, Marquardt Jens U, Roberts Lewis R, Oliveira Rui C, Koshiol Jill, O'Rourke Colm J, Andersen Jesper B
Biotech Research & Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark.
Biotech Research & Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
J Hepatol. 2023 Feb;78(2):364-375. doi: 10.1016/j.jhep.2022.10.012. Epub 2022 Oct 28.
BACKGROUND & AIMS: Cholangiocarcinoma (CCA) is a heterogeneous and lethal malignancy, the molecular origins of which remain poorly understood. MicroRNAs (miRs) target diverse signalling pathways, functioning as potent epigenetic regulators of transcriptional output. We aimed to characterise miRNome dysregulation in CCA, including its impact on transcriptome homeostasis and cell behaviour.
Small RNA sequencing was performed on 119 resected CCAs, 63 surrounding liver tissues, and 22 normal livers. High-throughput miR mimic screens were performed in three primary human cholangiocyte cultures. Integration of patient transcriptomes and miRseq together with miR screening data identified an oncogenic miR for characterization. MiR-mRNA interactions were investigated by a luciferase assay. MiR-CRISPR knockout cells were generated and phenotypically characterized in vitro (proliferation, migration, colony, mitochondrial function, glycolysis) and in vivo using subcutaneous xenografts.
In total, 13% (140/1,049) of detected miRs were differentially expressed between CCA and surrounding liver tissues, including 135 that were upregulated in tumours. CCA tissues were characterised by higher miRNome heterogeneity and miR biogenesis pathway expression. Unsupervised hierarchical clustering of tumour miRNomes identified three subgroups, including distal CCA-enriched and IDH1 mutant-enriched subgroups. High-throughput screening of miR mimics uncovered 71 miRs that consistently increased proliferation of three primary cholangiocyte models and were upregulated in CCA tissues regardless of anatomical location, among which only miR-27a-3p had consistently increased expression and activity in several cohorts. FoxO signalling was predominantly downregulated by miR-27a-3p in CCA, partially through targeting of FOXO1. MiR-27a knockout increased FOXO1 levels in vitro and in vivo, impeding tumour behaviour and growth.
The miRNomes of CCA tissues are highly remodelled, impacting transcriptome homeostasis in part through regulation of transcription factors like FOXO1. MiR-27a-3p arises as an oncogenic vulnerability in CCA.
Cholangiocarcinogenesis entails extensive cellular reprogramming driven by genetic and non-genetic alterations, but the functional roles of these non-genetic events remain poorly understood. By unveiling global miRNA upregulation in patient tumours and their functional ability to increase proliferation of cholangiocytes, these small non-coding RNAs are implicated as critical non-genetic alterations promoting biliary tumour initiation. These findings identify possible mechanisms for transcriptome rewiring during transformation, with potential implications for patient stratification.
胆管癌(CCA)是一种异质性且致命的恶性肿瘤,其分子起源仍知之甚少。微小RNA(miR)靶向多种信号通路,作为转录输出的有效表观遗传调节因子发挥作用。我们旨在表征CCA中miR组失调情况,包括其对转录组稳态和细胞行为的影响。
对119例切除的CCA、63例周围肝组织和22例正常肝脏进行小RNA测序。在三种原代人胆管细胞培养物中进行高通量miR模拟物筛选。将患者转录组和miRseq与miR筛选数据整合,鉴定出一种致癌miR进行表征。通过荧光素酶测定研究miR与mRNA的相互作用。生成miR - CRISPR敲除细胞,并在体外(增殖、迁移、集落形成、线粒体功能、糖酵解)和体内使用皮下异种移植进行表型特征分析。
总共13%(140/1049)检测到的miR在CCA和周围肝组织之间差异表达,其中135个在肿瘤中上调。CCA组织的特征是miR组异质性和miR生物合成途径表达更高。肿瘤miR组的无监督层次聚类确定了三个亚组,包括富含远端CCA和富含异柠檬酸脱氢酶1(IDH1)突变体的亚组。miR模拟物的高通量筛选发现71个miR持续增加三种原代胆管细胞模型的增殖,并且在CCA组织中上调,无论解剖位置如何,其中只有miR - 27a - 3p在几个队列中持续增加表达和活性。在CCA中,FoxO信号主要被miR - 27a - 3p下调,部分是通过靶向FOXO1。miR - 27a敲除在体外和体内增加FOXO1水平,阻碍肿瘤行为和生长。
CCA组织的miR组高度重塑,部分通过调节FOXO1等转录因子影响转录组稳态。miR - 27a - 3p成为CCA中的致癌弱点。
胆管癌发生需要由遗传和非遗传改变驱动的广泛细胞重编程,但这些非遗传事件的功能作用仍知之甚少。通过揭示患者肿瘤中全局miRNA上调及其增加胆管细胞增殖的功能能力,这些小非编码RNA被认为是促进胆管肿瘤发生的关键非遗传改变。这些发现确定了转化过程中转录组重新布线的可能机制,对患者分层具有潜在意义。